Whether or not the transiency of the PD-1 antibody-associated increases in cytokine levels in the spleen and tongue in our premalignant oral lesion model is due to shifts to other immune checkpoints or due to interference in IFN-γ signaling has not yet been determined. The gene discussed is PDCD1; the disease is dysplastic oral keratinocyte.